Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.53 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.53 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11295189 | 0.89 | ALDH1A1 (0.62) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A | |
| SCHEMBL28401182 | 0.87 | ALDH1A1 (0.72) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A | |
| SCHEMBL3803167 | 0.87 | ALDH1A1 (0.77) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A | |
| SCHEMBL21059173 | 0.87 | SMN1; SMN2 (0.63) | ALDH1A1SMN1; SMN2MEN1KMT2ANPC1 | |
| SCHEMBL3788964 | 0.85 | ALDH1A1 (0.75) | ALDH1A1HPGDSMN1; SMN2MAPTCYP1A2 | |
| SCHEMBL23727249 | 0.85 | ALDH1A1 (0.57) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL30130809 | 0.85 | ALDH1A1 (0.57) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL3784358 | 0.84 | ALDH1A1 (0.73) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A | |
| SCHEMBL21059156 | 0.84 | SMN1; SMN2 (0.66) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A | |
| SCHEMBL18415553 | 0.83 | GPR35 (0.74) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115989220-A | Amido cyclohexanoic acid derivatives as LPA receptor inhibitors | 奇斯药制品公司 | 2023-04-18 | — | — | CN | disclosed |
| EP-3508473-B1 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | AIST (JP) | 2021-05-26 | — | — | EP | disclosed |
| US-10752579-B2 | Production method of carbamic acid ester | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2020-08-25 | — | — | US | disclosed |
| EP-3508473-A1 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | National Institute of Advanced Industrial Science and Technology (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-20190185420-A1 | PRODUCTION METHOD OF CARBAMIC ACID ESTER | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2019-06-20 | — | — | US | disclosed |
| US-20110155660-A1 | MODIFIED MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC | 2011-06-30 | — | — | US | disclosed |
| US-7882963-B2 | modifying polyamide discriminating layer ( e.g metaphenylene diamine- trimesoyl chloride monomers) with aminoacetophenone or aminothiophenol; fouling resistant surface, improved salt rejection, antimicrobial properties, improved solute, and/or small organics rejection; for water purification | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-02-08 | — | — | US | disclosed |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| US-20090159527-A1 | MODIFIED MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC | 2009-06-25 | — | — | US | disclosed |
| US-7439382-B2 | 4-alkyl-2-haloaniline derivatives and process for producing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2008-10-21 | — | — | US | disclosed |
| WO-2007133362-A1 | MODIFIED MEMBRANE | DOW GLOBAL TECHNOLOGIES INC. (US) | 2007-11-22 | — | — | WO | disclosed |
| US-6939887-B2 | Benzimidazolidinone derivatives | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2005-09-06 | — | — | US | disclosed |
| US-20050143454-A1 | 4-Alkyl-2-haloaniline derivative and process and process for producing the same | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2005-06-30 | — | — | US | disclosed |
| EP-1506954-A1 | 4-ALKYL-2-HALOANILINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | MEIJI SEIKA KAISHA LTD. (JP) | 2005-02-16 | — | — | EP | disclosed |
| US-20040142850-A1 | Benzimidazolidinone derivatives | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2004-07-22 | — | — | US | disclosed |
| EP-1364945-A1 | BENZIMIDAZOLIDINONE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2003-11-26 | — | — | EP | disclosed |
| EP-0032733-B1 | PROCESS FOR PREPARING POLYMETHYLENE POLYPHENYL POLYCARBAMATES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1984-06-13 | — | — | EP | disclosed |
| US-4328354-A | Preparation of methylene-bis-phenylcarbamic acid esters and polymethylene-polyphenylcarbamic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 1982-05-04 | — | — | US | disclosed |
| US-4282370-A | Preparation of methylene-bis-phenylcarbamic acid esters and of polymethylene-polyphenylcarbamic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 1981-08-04 | — | — | US | disclosed |
| EP-0032733-A1 | Process for preparing polymethylene polyphenyl polycarbamates | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1981-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | ALDH1A1 4339/4885HPGD 2790/4885SMN1; SMN2 4524/4885 |
| US-20040142850-A1 | Benzimidazolidinone derivatives | GHSR, GHRHR, PRLHR | ALDH1A1 2586/4885HPGD 2766/4885SMN1; SMN2 3071/4885 |
| US-20050143454-A1 | 4-Alkyl-2-haloaniline derivative and process and process for producing the same | NAT1, CYP4X1, HAX1 | ALDH1A1 441/4885HPGD 1153/4885SMN1; SMN2 4051/4885 |
| US-20190185420-A1 | PRODUCTION METHOD OF CARBAMIC ACID ESTER | CA2, CA7, CA4 | ALDH1A1 3215/4885HPGD 3008/4885SMN1; SMN2 3068/4885 |
| US-10752579-B2 | Production method of carbamic acid ester | CA2, CA7, CA4 | ALDH1A1 3215/4885HPGD 3008/4885SMN1; SMN2 3068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.